EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Minimal Clinically Important Differences in Measuring Treatment Effects in CIDP : History, Current Use, Limitations, and Prospects

Yusuf A Rajabally iD, Kabir K Nazeer, Young Gi Min iD

Muscle & Nerve · 2025

DOI: 10.1002/mus.28478 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Muscle & Nerve, 2025. Verfasst von Yusuf A Rajabally und 2 weiteren Autor:innen. Beteiligte Einrichtung: Aston Medical School, Aston University, Birmingham, UK. Hauptthemen laut MEDLINE: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Minimal Clinically Important Difference, Outcome Assessment, Health Care. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Outcome measures are essential for evaluating treatment effects and disease progression in chronic inflammatory demyelinating polyneuropathy (CIDP). The concept of the minimal clinically important difference (MCID), which represents the smallest change in a measure deemed clinically meaningful, has become increasingly important in CIDP research, and is also gaining interest in clinical practice. This review explores the history of use in clinical trials and observational studies, as well as potential limitations and future perspectives for MCIDs in CIDP. MCID derivation methods include anchor‐based approaches that rely on patient perspectives, and distribution‐based methods that calculate the magnitude of changes exceeding statistical error margins. Both approaches have been used in CIDP, yielding MCID cut‐offs for key scales such as the Inflammatory Neuropathy Cause and Treatment (INCAT) Scale, Overall Neuropathy Limitation Scale (ONLS), Rasch‐built Overall Disability Scale (I‐RODS), grip strength, and the Medical Research Council sum score. Challenges include discrepancies in MCID thresholds, particularly for I‐RODS and strength measures, and variability related to disease severity and subtype. Despite these issues, MCIDs for disability measures such as INCAT, ONLS, and I‐RODS have demonstrated their value through validity and clinical relevance, making them suitable for both research and clinical practice. MCIDs for strength scores, walking tests, sensory scales, and electrophysiological measures lack reliability and direct clinical relevance with regard to the primary concept of clinically meaningful benefit. Future research should focus on optimization of outcome measures, harmonization of MCID derivation methods, and exploration of MCID application with disease‐specific Health Related‐Quality of Life measures for CIDP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polyradiculoneuropathy, Chronic Inflammatory DemyelinatingMinimal Clinically Important DifferenceOutcome Assessment, Health CareHumansDisability EvaluationTreatment Outcome

Stichwörter der Autor:innen

chronic inflammatory demyelinating polyneuropathyminimal clinically important differencesoutcome measurestreatmenttrial

Autor:innen und Institutionen

  • Aston Medical School, Aston University, Birmingham, UK.
  • Department of Neurology, Inflammatory Neuropathy Clinic, University Hospitals Birmingham, Birmingham, UK.
  • Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Yusuf A Rajabally, Young Gi Min

Zitieren

APA

Rajabally, Y. A., Nazeer, K. K., & Min, Y. G. (2025). Minimal Clinically Important Differences in Measuring Treatment Effects in CIDP : History, Current Use, Limitations, and Prospects. Muscle & Nerve. https://doi.org/10.1002/mus.28478

Vancouver

Rajabally YA, Nazeer KK, Min YG. Minimal Clinically Important Differences in Measuring Treatment Effects in CIDP : History, Current Use, Limitations, and Prospects. Muscle & Nerve. 2025. doi:10.1002/mus.28478

BibTeX
@article{Rajabally2025,
  author = {Rajabally, Yusuf A and Nazeer, Kabir K and Min, Young Gi},
  title = {Minimal Clinically Important Differences in Measuring Treatment Effects in CIDP : History, Current Use, Limitations, and Prospects},
  journal = {Muscle & Nerve},
  year = {2025},
  doi = {10.1002/mus.28478}
}
Kostenlos starten →